Hims & Hers is transforming telehealth with personalized medications, rapid subscription growth, and strong financials, ...

The Short discusses a 15% drop in Hims & Hers stock following an FDA announcement ending the shortage of Eli Lilly's weight ...

Craig Hettenbach, an analyst from Morgan Stanley, maintained the Buy rating on Hims & Hers Health (HIMS – Research Report). The associated ...

Hims recaps the year's most surprising health findings, from the growing number of adults who consider monogamy optional to ...

Rahul Sahai, Chairman of the Indian Chamber of Commerce (ICC) Jammu chapter and a prominent business leader from Jammu and ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot capped a volatile year for investors in drug ...

Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and ...

Oza’s new Miami Beach home was built in 1936 and sculpted by architect Lawrence Murray Dixon, who owned it as a personal ...

In 2024, the U.S. economy experienced significant fluctuations. Throughout the year, investors keen on investing in MedTech ...

Pilot and Mosh also offer hair loss treatments, but The Hairy Pill sets itself apart by combining multiple active ingredients ...

The antioxidant lycopene in watermelon may help protect your prostate gland and improve fertility, while citrulline, an amino ...